Diabetes Care, Vol 23, Issue 8 1108-1112, Copyright © 2000 by American Diabetes Association

ARTICLES

The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes

MM Gabir, RL Hanson, D Dabelea, G Imperatore, J Roumain, PH Bennett and WC Knowler
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85014, USA.

OBJECTIVE: The 1997 American Diabetes Association (ADA) and the 1985 and 1999 World Health Organization (WHO) criteria for diabetes and hyperglycemia differ. The appropriateness of these diagnostic criteria in terms of individuals identified as abnormal and their prognosis has been debated. The purpose of this study is to compare the classifications of people by these criteria and to compare fasting and postload plasma glucose concentrations in the prediction of diabetes. RESEARCH DESIGN AND METHODS: The frequencies of diabetes by the 3 sets of criteria were compared in 5,023 adult Pima Indians not taking hypoglycemic drugs. Among nondiabetic subjects, fasting plasma glucose (FPG) and 2-h postload plasma glucose (2-h PG) concentrations and categories of impaired glucose regulation or diabetes were evaluated as predictors of diabetes defined by 1999 WHO criteria. RESULTS: The frequency of diabetes was 12.5% by 1997 ADA criteria, 14.6% by 1985 WHO criteria, and 15.3% by 1999 WHO criteria. The incidence of diabetes was strongly related to higher FPG and 2-h PG, each of which had very similar predictive powers. Impaired glucose tolerance (IGT) was more common than impaired fasting glucose (IFG) (15 vs. 5%), but the 5-year incidence of diabetes was higher in IFG than IGT (37 vs. 24%). CONCLUSIONS: The prevalence and incidence of diabetes are somewhat lower with the ADA criteria than with the 1985 or 1999 WHO criteria. The intermediate categories of glycemia differ substantially IFG defines a smaller number of people who are at higher risk of developing diabetes than those with IGT. More people at high risk of diabetes could be identified by using either IFG or IGT, as recommended by the 1999 WHO criteria, or by using the FPG concentration alone, but with a lower cutoff value.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E Goyder, S Wild, C Fischbacher, J Carlisle, and J Peters Evaluating the impact of a national pilot screening programme for type 2 diabetes in deprived areas of England Fam. Pract., October 1, 2008; 25(5): 370 - 375. [Abstract] [Full Text] [PDF]

				M. A. Abdul-Ghani, M. Matsuda, R. Jani, C. P. Jenkinson, D. K. Coletta, K. Kaku, and R. A. DeFronzo The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E401 - E406. [Abstract] [Full Text] [PDF]

				Y. Zhang, X. Li, D. Zou, W. Liu, J. Yang, N. Zhu, L. Huo, M. Wang, J. Hong, P. Wu, et al. Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2559 - 2565. [Abstract] [Full Text] [PDF]

				J.-W. Kwon, Y.-m. Song, H. s. Park, J. Sung, H. Kim, and S.-i. Cho Effects of Age, Time Period, and Birth Cohort on the Prevalence of Diabetes and Obesity in Korean Men Diabetes Care, February 1, 2008; 31(2): 255 - 260. [Abstract] [Full Text] [PDF]

				American Diabetes Association Standards of Medical Care in Diabetes--2008 Diabetes Care, January 1, 2008; 31(Supplement_1): S12 - S54. [Full Text] [PDF]

				K. E. S. Salley, E. P. Wickham, K. I. Cheang, P. A. Essah, N. W. Karjane, and J. E. Nestler POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome A Position Statement of the Androgen Excess Society J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4546 - 4556. [Abstract] [Full Text] [PDF]

				I. Harman-Boehm, M. Bluher, H. Redel, N. Sion-Vardy, S. Ovadia, E. Avinoach, I. Shai, N. Kloting, M. Stumvoll, N. Bashan, et al. Macrophage Infiltration into Omental Versus Subcutaneous Fat across Different Populations: Effect of Regional Adiposity and the Comorbidities of Obesity J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2240 - 2247. [Abstract] [Full Text] [PDF]

				A. M. Hodge, D. R. English, K. O'Dea, and G. G. Giles Dietary Patterns and Diabetes Incidence in the Melbourne Collaborative Cohort Study Am. J. Epidemiol., March 15, 2007; 165(6): 603 - 610. [Abstract] [Full Text] [PDF]

				D. M. Nathan, M. B. Davidson, R. A. DeFronzo, R. J. Heine, R. R. Henry, R. Pratley, and B. Zinman Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care Diabetes Care, March 1, 2007; 30(3): 753 - 759. [Full Text] [PDF]

				G. A. Nichols, T. A. Hillier, and J. B. Brown Progression From Newly Acquired Impaired Fasting Glusose to Type 2 Diabetes Diabetes Care, February 1, 2007; 30(2): 228 - 233. [Abstract] [Full Text] [PDF]

				American Diabetes Association Standards of Medical Care in Diabetes--2007 Diabetes Care, January 1, 2007; 30(suppl_1): S4 - S41. [Full Text] [PDF]

				E. C. Chambers, S. Heshka, D. Gallagher, J. Wang, F. X. Pi-Sunyer, and R. N. Pierson Jr Serum Magnesium and Type-2 Diabetes in African Americans and Hispanics: A New York Cohort J. Am. Coll. Nutr., December 1, 2006; 25(6): 509 - 513. [Abstract] [Full Text] [PDF]

				T. Cascella, S. Palomba, L. Tauchmanova, F. Manguso, S. Di Biase, D. Labella, F. Giallauria, C. Vigorito, A. Colao, G. Lombardi, et al. Serum Aldosterone Concentration and Cardiovascular Risk in Women with Polycystic Ovarian Syndrome J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4395 - 4400. [Abstract] [Full Text] [PDF]

				M. A. Abdul-Ghani, D. Tripathy, and R. A. DeFronzo Contributions of {beta}-Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose Diabetes Care, May 1, 2006; 29(5): 1130 - 1139. [Abstract] [Full Text] [PDF]

				S.M. Kim, J.S. Lee, J. Lee, J.K. Na, J.H. Han, D.K. Yoon, S.H. Baik, D.S. Choi, and K.M. Choi Prevalence of Diabetes and Impaired Fasting Glucose in Korea: Korean National Health and Nutrition Survey 2001 Diabetes Care, February 1, 2006; 29(2): 226 - 231. [Abstract] [Full Text] [PDF]

				K. A. Armstrong, J. B. Prins, E. M. Beller, S. B. Campbell, C. M. Hawley, D. W. Johnson, and N. M. Isbel Should an Oral Glucose Tolerance Test Be Performed Routinely in All Renal Transplant Recipients? Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 100 - 108. [Abstract] [Full Text] [PDF]

				American Diabetes Association Standards of Medical Care in Diabetes-2006 Diabetes Care, January 1, 2006; 29(suppl_1): S4 - S42. [Full Text] [PDF]

				A. Tirosh, I. Shai, D. Tekes-Manova, E. Israeli, D. Pereg, T. Shochat, I. Kochba, A. Rudich, and the Israeli Diabetes Research Group Normal Fasting Plasma Glucose Levels and Type 2 Diabetes in Young Men N. Engl. J. Med., October 6, 2005; 353(14): 1454 - 1462. [Abstract] [Full Text] [PDF]

				J. Curtis and C. Wilson Preventing Type 2 Diabetes Mellitus J Am Board Fam Med, January 1, 2005; 18(1): 37 - 43. [Abstract] [Full Text] [PDF]

				F. Orio Jr., S. Palomba, T. Cascella, S. Di Biase, F. Manguso, L. Tauchmanova, L. G. Nardo, D. Labella, S. Savastano, T. Russo, et al. The Increase of Leukocytes as a New Putative Marker of Low-Grade Chronic Inflammation and Early Cardiovascular Risk in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 2 - 5. [Abstract] [Full Text] [PDF]

				D. A. Ehrmann, K. Kasza, R. Azziz, R. S. Legro, M. N. Ghazzi, and for the PCOS/Troglitazone Study Group Effects of Race and Family History of Type 2 Diabetes on Metabolic Status of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 66 - 71. [Abstract] [Full Text] [PDF]

				American Diabetes Association Standards of Medical Care in Diabetes Diabetes Care, January 1, 2005; 28(suppl_1): S4 - S36. [Full Text] [PDF]

				N. M. Punjabi, E. Shahar, S. Redline, D. J. Gottlieb, R. Givelber, and H. E. Resnick Sleep-Disordered Breathing, Glucose Intolerance, and Insulin Resistance: The Sleep Heart Health Study Am. J. Epidemiol., September 15, 2004; 160(6): 521 - 530. [Abstract] [Full Text] [PDF]

				A. M. Sironi, A. Gastaldelli, A. Mari, D. Ciociaro, V. Postano, E. Buzzigoli, S. Ghione, S. Turchi, M. Lombardi, and E. Ferrannini Visceral Fat in Hypertension: Influence on Insulin Resistance and {beta}-Cell Function Hypertension, August 1, 2004; 44(2): 127 - 133. [Abstract] [Full Text] [PDF]

				E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, J. B. Meigs, R. C. Bonadonna, and M. Muggeo Population-Based Incidence Rates and Risk Factors for Type 2 Diabetes in White Individuals: The Bruneck Study Diabetes, July 1, 2004; 53(7): 1782 - 1789. [Abstract] [Full Text] [PDF]

				J. B. Meigs, K. Williams, L. M. Sullivan, K. J. Hunt, S. M. Haffner, M. P. Stern, C. Gonzalez Villalpando, J. S. Perhanidis, D. M. Nathan, R. B. D'Agostino Jr, et al. Using Metabolic Syndrome Traits for Efficient Detection of Impaired Glucose Tolerance Diabetes Care, June 1, 2004; 27(6): 1417 - 1426. [Abstract] [Full Text] [PDF]

				G. Hu, J. Lindstrom, T. T. Valle, J. G. Eriksson, P. Jousilahti, K. Silventoinen, Q. Qiao, and J. Tuomilehto Physical Activity, Body Mass Index, and Risk of Type 2 Diabetes in Patients With Normal or Impaired Glucose Regulation Arch Intern Med, April 26, 2004; 164(8): 892 - 896. [Abstract] [Full Text] [PDF]

				Expert Committee on the Diagnosis and Classificati Follow-up Report on the Diagnosis of Diabetes Mellitus Clin. Diabetes, April 1, 2004; 22(2): 71 - 79. [Full Text] [PDF]

				Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Spectr, January 1, 2004; 17(1): 51 - 59. [Full Text] [PDF]

				Prevention or Delay of Type 2 Diabetes Diabetes Care, January 1, 2004; 27(90001): s47 - 47. [Full Text] [PDF]

				D.-J. Kim, K.-W. Kim, N.-H. Cho, J.-H. Noh, M.-S. Lee, and M.-K. Lee The Cutoff Value of Fasting Plasma Glucose to Differentiate Frequencies of Cardiovascular Risk Factors in a Korean Population Diabetes Care, December 1, 2003; 26(12): 3354 - 3356. [Full Text] [PDF]

				The Expert Committee on the Diagnosis and Classifi Follow-up Report on the Diagnosis of Diabetes Mellitus Diabetes Care, November 1, 2003; 26(11): 3160 - 3167. [Full Text] [PDF]

				Q. Qiao, P. Jousilahti, J. Eriksson, and J. Tuomilehto Predictive Properties of Impaired Glucose Tolerance for Cardiovascular Risk Are Not Explained by the Development of Overt Diabetes During Follow-Up Diabetes Care, October 1, 2003; 26(10): 2910 - 2914. [Abstract] [Full Text] [PDF]

				S. Malozowski Use of Growth Hormone in Elderly Individuals JAMA, July 23, 2003; 290(4): 462 - 462. [Full Text] [PDF]

				J. B. Meigs, D. C. Muller, D. M. Nathan, D. R. Blake, and R. Andres The Natural History of Progression From Normal Glucose Tolerance to Type 2 Diabetes in the Baltimore Longitudinal Study of Aging Diabetes, June 1, 2003; 52(6): 1475 - 1484. [Abstract] [Full Text] [PDF]

				M. J. McNeely, E. J. Boyko, D. L. Leonetti, S. E. Kahn, and W. Y. Fujimoto Comparison of a Clinical Model, the Oral Glucose Tolerance Test, and Fasting Glucose for Prediction of Type 2 Diabetes Risk in Japanese Americans Diabetes Care, March 1, 2003; 26(3): 758 - 763. [Abstract] [Full Text] [PDF]

				D. R. Jesudason, K. Dunstan, D. Leong, and G. A. Wittert Macrovascular Risk and Diagnostic Criteria for Type 2 Diabetes: Implications for the use of FPG and HbA1c for cost-effective screening Diabetes Care, February 1, 2003; 26(2): 485 - 490. [Abstract] [Full Text] [PDF]

				D. M Nathan Preventing type 2 diabetes: what have we learned? The British Journal of Diabetes & Vascular Disease, January 1, 2003; 3(1_suppl): S6 - S11. [Abstract] [PDF]

				The Prevention or Delay of Type 2 Diabetes Diabetes Care, January 1, 2003; 26(90001): s62 - 69. [Full Text] [PDF]

				J. H. Cole, E. L. Jones, J. M. Craver, R. A. Guyton, D. C. Morris, J. S. Douglas Jr, Z. Ghazzal, and W. S. Weintraub Outcomes of repeat revascularization in diabetic patients with prior coronary surgery J. Am. Coll. Cardiol., December 4, 2002; 40(11): 1968 - 1975. [Abstract] [Full Text] [PDF]

				R G. Barr, D. M. Nathan, J. B. Meigs, and D. E. Singer Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus Ann Intern Med, August 20, 2002; 137(4): 263 - 272. [Abstract] [Full Text] [PDF]

				The Prevention or Delay of Type 2 Diabetes Clin. Diabetes, July 1, 2002; 20(3): 109 - 116. [Full Text] [PDF]

				The Prevention or Delay of Type 2 Diabetes Diabetes Spectr, July 1, 2002; 15(3): 147 - 157. [Full Text] [PDF]

				American Diabetes Association The Prevention or Delay of Type 2 Diabetes Diabetes Care, April 1, 2002; 25(4): 742 - 749. [Full Text] [PDF]

				Diabetes Prevention Program Research Group Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin N. Engl. J. Med., February 7, 2002; 346(6): 393 - 403. [Abstract] [Full Text] [PDF]

				J. A. Tayek Is Weight Loss a Cure for Type 2 Diabetes? Diabetes Care, February 1, 2002; 25(2): 397 - 398. [Full Text] [PDF]

				H. C. Gerstein Fasting Versus Postload Glucose Levels: Why the controversy? Diabetes Care, November 1, 2001; 24(11): 1855 - 1857. [Full Text] [PDF]

				K. Ranade, K. D. Wu, N. Risch, M. Olivier, D. Pei, C.-F. Hsiao, L.-M. Chuang, L.-T. Ho, E. Jorgenson, R. Pesich, et al. Genetic variation in aldosterone synthase predicts plasma glucose levels PNAS, October 25, 2001; (2001) 221467098. [Abstract] [Full Text] [PDF]

				K. Ranade, K. D. Wu, N. Risch, M. Olivier, D. Pei, C.-F. Hsiao, L.-M. Chuang, L.-T. Ho, E. Jorgenson, R. Pesich, et al. Genetic variation in aldosterone synthase predicts plasma glucose levels PNAS, November 6, 2001; 98(23): 13219 - 13224. [Abstract] [Full Text] [PDF]